These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 9750490)

  • 1. [A pilot study of mass screening program for prostatic cancer by means of prostate specific antigen (PSA) filter paper method].
    Nakagawa S; Watanabe H; Watanabe M; Nomoto T; Nakamura T; Sugimoto K; Saitoh M; Kojima M; Kitamura K
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):399-405. PubMed ID: 9125863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A; Shotland Y; Metz Y; Stein A
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer.
    Pode D; Shapiro A; Lebensart P; Meretyk S; Katz G; Barak V
    Isr J Med Sci; 1995; 31(2-3):125-8. PubMed ID: 7538101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of cancer of the prostate: study in a Spanish population].
    Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A
    Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass screening for prostate cancer].
    Ito K; Yamamoto T; Kubota Y; Yamanaka H
    Nihon Rinsho; 2000 Jul; 58 Suppl():365-8. PubMed ID: 11022750
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostatic mass screening program and its technology].
    Watanabe H; Nakagawa S
    Nihon Rinsho; 1998 Aug; 56(8):1974-7. PubMed ID: 9750490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass screening program for prostatic cancer in Japan.
    Watanabe H
    Int J Clin Oncol; 2001 Apr; 6(2):66-73. PubMed ID: 11706752
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.